A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/07/2011	EP2392330A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392329A1 Compositions for use in treating myelodysplastic syndrome
12/07/2011	EP2392328A1 Compounds for modulating TRPV3 Function
12/07/2011	EP2392327A1 Use of orlistat for the anti-parasitic treatment of a parasitic disease
12/07/2011	EP2392326A1 Silibinin component for the treatment of hepatitis
12/07/2011	EP2392325A1 Compounds for the prevention and/or treatment of osteoarthrosis
12/07/2011	EP2392324A1 Rhenium complexes and their pharmaceutical use
12/07/2011	EP2392323A1 Prostate cancer progression inhibitor and progression inhibition method
12/07/2011	EP2392322A2 Dosing regimes for trans-clomiphene
12/07/2011	EP2392321A1 Combined composition for rectal administration for the treatment of inflammatory bowel disease
12/07/2011	EP2392320A1 Treatment of inflammatory diseases
12/07/2011	EP2392319A1 Pharmaceutical compositions of co-crystals of tramadol and coxibs
12/07/2011	EP2392318A1 A pharmaceutical controlled release composition of losartan
12/07/2011	EP2391717A1 Treatment of radiation-induced fibrosis
12/07/2011	EP2391658A1 Molecularly imprinted polymers
12/07/2011	EP2391656A1 Low molecular weight sulphated polysaccharides as candidates for anti-angiogenic therapy
12/07/2011	EP2391630A2 Anti-cancer protein-platinum conjugates
12/07/2011	EP2391629A1 Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
12/07/2011	EP2391628A1 2-aza-bicycloý2.2.1¨heptane compounds and uses thereof
12/07/2011	EP2391627A2 Bicyclic pyrazolo-heterocycles
12/07/2011	EP2391626A2 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
12/07/2011	EP2391625A1 New adenosine receptor ligands and uses thereof
12/07/2011	EP2391624A1 Azaquinazolinediones useful as chymase inhibitors
12/07/2011	EP2391621A2 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
12/07/2011	EP2391620A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
12/07/2011	EP2391619A1 Heteroaryls and their use as pi3k inhibitors
12/07/2011	EP2391618A2 Cromolyn derivatives and related methods of imaging and treatment
12/07/2011	EP2391617A1 Azetidines as histamine h3 receptor antagonists
12/07/2011	EP2391616A1 Carboxamide compounds and methods for using the same
12/07/2011	EP2391615A1 Piperidine derivatives as nk3 receptor antagonists
12/07/2011	EP2391611A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
12/07/2011	EP2391609A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
12/07/2011	EP2391607A1 Novel process for preparing carboxy-containing pyrazoleamido compounds 597
12/07/2011	EP2391606A1 Ethanamine compounds and their use for treating depression
12/07/2011	EP2391605A1 Scriptaid isosteres and their use in therapy
12/07/2011	EP2391604A1 Dihydropyridone amides as p2x7 modulators
12/07/2011	EP2391603A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
12/07/2011	EP2391602A1 Carbazole carboxamide compounds useful as kinase inhibitors
12/07/2011	EP2391375A1 Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement
12/07/2011	EP2391372A1 Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
12/07/2011	EP2391371A2 A high molecular weight polysaccharide that binds and inhibits virus
12/07/2011	EP2391370A1 Methods and compositions for treating alzheimer's disease
12/07/2011	EP2391369A1 Delayed-release glucocorticoid treatment of asthma
12/07/2011	EP2391368A1 Drug abuse deterrent, methods and compositions
12/07/2011	EP2391367A1 Nampt and vitamin b3 for treating or preventing diseases
12/07/2011	EP2391366A1 Substituted benzimidazoles for the treatment of astrocytomas
12/07/2011	EP2391365A2 Solid pharmaceutical composition comprising amlodipine and losartan
12/07/2011	EP2391364A1 Methods to treat cancer
12/07/2011	EP2391363A2 Compositions and methods for the treatment of cancer
12/07/2011	EP2391362A2 Preservation of ergothioneine
12/07/2011	EP2391361A1 Methods for improving cognitive function and decreasing heart rate
12/07/2011	EP2391360A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
12/07/2011	EP2391359A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
12/07/2011	EP2391358A1 Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists
12/07/2011	EP2391356A1 Treatment of psoriasis
12/07/2011	EP2391355A2 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
12/07/2011	EP2391354A1 Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
12/07/2011	EP2391353A1 Pharmaceutical compositions of trimetazidine
12/07/2011	EP2391352A1 Pharmaceutical forms for the release of active compounds
12/07/2011	EP2391351A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
12/07/2011	EP2391350A1 Atazanavir formulations
12/07/2011	EP2391349A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
12/07/2011	EP2391348A1 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
12/07/2011	EP2391346A1 Solid oral formulations of a pyridopyrimidinone
12/07/2011	EP2391345A1 Galenic formulations of organic compounds
12/07/2011	EP2391344A1 Compositions for nail and skin treatment
12/07/2011	EP2391230A2 Composition comprising caftaric acid and/or derivatives thereof
12/07/2011	EP2391228A1 Composition comprising chicoric acid and/or derivatives thereof
12/07/2011	EP2391212A1 Bridged compounds as hiv integrase inhibitors
12/07/2011	EP2391211A1 Methods and compositions for treating breast cancer
12/07/2011	EP2391209A1 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
12/07/2011	EP2391208A1 Compositions for nail and skin treatment
12/07/2011	EP2321300B1 Chlorophyll catabolites
12/07/2011	EP2297176B1 Novel nucleic acid transfer system
12/07/2011	EP2257283B1 L-citrulline for treating erectile dysfunction
12/07/2011	EP2158205B1 3,3-spiroindolinone derivatives as anticancer agents
12/07/2011	EP2104677B1 Spiropiperidine glycinamide derivatives
12/07/2011	EP1981881B1 Tetrahydropyrane antibiotics
12/07/2011	EP1968571B1 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
12/07/2011	EP1965790B1 Metabolites of wortmannin analogs and methods of using the same
12/07/2011	EP1957477B1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
12/07/2011	EP1940832B1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
12/07/2011	EP1841420B1 Treatment of drug-resistant proliferative disorders
12/07/2011	EP1802291B1 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
12/07/2011	EP1799225B1 Use of paullone derivates for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
12/07/2011	EP1766035B1 Lipid encapsulated interfering rna
12/07/2011	EP1765349B9 Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
12/07/2011	EP1677775B1 Therapeutic use of methionine for the treatment or prevention of mucositis
12/07/2011	EP1671618B1 Composition for promoting collagen production
12/07/2011	EP1660467B1 2-(4-amino-1,2,5-oxadiazol-4-yl)-imidazole compounds useful as protein kinase inhibitors
12/07/2011	EP1608733B1 Modified polynucleotides for use in rna interference
12/07/2011	EP1549276B1 Drug eluting coatings for medical implants
12/07/2011	EP1476138B1 Modified release formulations of at least one form of tramadol
12/07/2011	EP1450605B1 Composition to alter bone properties in a subject
12/07/2011	EP1420851B1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
12/07/2011	EP1372668B1 Method of attenuating reactions to skin irritants
12/07/2011	EP1156033B1 Process for producing acidic n-(long-chain acyl)amino acid
12/07/2011	EP0515460B2 Docosahexaenoic acid, methods for its production and compounds containing the same
12/07/2011	CN1960731B 调节炎性和转移过程的方法 Inflammatory and method transfer process
12/07/2011	CN1960719B 棉酚共结晶及其应用 Gossypol co-crystallization and Its Applications

1 ... 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 ... 7860